TABLE 2.
Outcomes for urinary retention and urinary tract infection among men and women in the 6 months following injection with onabotulinumtoxin A
| Outcome | Men, N = 48 | Women, N = 230 | p value |
|---|---|---|---|
| Urinary retention | |||
| Started CIC within 6 months | 13 (27.1) | 32 (13.9) | 0.02 |
| Postvoid residual | |||
| Mean (SD) | 162.4 (156.9) | 125.8 (127.4) | 0.34 |
| Median (range) | 119.5 (0–500) | 82 (0–530) | |
| PVR value, N (%) | |||
| <200 ml | 27 (61.4) | 155 (75.6) | 0.04 |
| 200–299 ml | 6 (13.6) | 25 (12.2) | |
| ≥300 ml | 11 (25.0) | 25 (12.2) | |
| Started CIC at the following PVR | 0.72 | ||
| <200 ml | 1 (8.3) | 6 (18.8) | |
| 200–299 ml | 4 (33.3) | 8 (25.0) | |
| ≥300 ml | 7 (52.3) | 18 (56.3) | |
| Total retention rate (started CIC or PVR ≥ 300 ml) | 17 (35.4) | 39 (17.0) | 0.004 |
| Urinary tract infection (UTI) | |||
| ≥1 UTI within 6 months | 8 (16.7) | 54 (23.5) | 0.30 |
| Number of UTIs per subject within 6 months | |||
| 0 | 40 (83.3) | 176 (76.5) | 0.30 |
| 1 | 6 (12.5) | 41 (17.8) | |
| 2 | 2 (4.2) | 7 (3.0) | |
| 3 | 0 | 5 (2.2) | |
| 4 | 0 | 1 (0.4) |
Abbreviations: CIC, clean intermittent catheterization; PVR, postvoid residual; UTI, urinary tract infection.